SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3h6t'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LBC_A_CYZA330_1 (GLUTAMINE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	8 / 12	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.35A	1lbcA-3h6tA: 44.1 1lbcC-3h6tA: 43.4	1lbcA-3h6tA: 100.00 1lbcC-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LBC_B_CYZB329_1 (GLUTAMINE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	9 / 9	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 ASP A 248 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) None CYZ A 265 ( 4.4A)	0.46A	1lbcB-3h6tA: 43.6	1lbcB-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LBC_C_CYZC331_1 (GLUTAMINE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	8 / 12	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.37A	1lbcA-3h6tA: 44.1 1lbcC-3h6tA: 43.4	1lbcA-3h6tA: 100.00 1lbcC-3h6tA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P91_A_SAMA1401_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE A)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 11	LEU A 138 GLY A 62 ILE A 11 TYR A 16 PRO A 15	GLU A 264 (-4.6A) None None None None	1.17A	1p91A-3h6tA: undetectable	1p91A-3h6tA: 21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VPO_H_TESH1010_1 (ANTI-TESTOSTERONE (HEAVY CHAIN) ANTI-TESTOSTERONE (LIGHT CHAIN))	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 12	ALA A 189 GLY A 136 LEU A 191 PHE A 147 VAL A 154	None	1.34A	1vpoH-3h6tA: undetectable 1vpoL-3h6tA: undetectable	1vpoH-3h6tA: 20.36 1vpoL-3h6tA: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EBZ_B_017B201_1 (PROTEASE)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 11	LEU A 39 ALA A 237 GLY A 231 ILE A 87 ILE A 43	None	0.83A	3ebzA-3h6tA: undetectable	3ebzA-3h6tA: 17.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IJX_B_HCZB800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 10	ILE A 92 PRO A 105 SER A 108 SER A 217 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) GOL A 270 ( 3.0A) None	0.64A	3ijxB-3h6tA: 42.8 3ijxD-3h6tA: 42.7	3ijxB-3h6tA: 100.00 3ijxD-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IJX_H_HCZH800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 5	LYS A 104 PRO A 105 LEU A 239 SER A 242	None CYZ A 265 (-3.9A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A)	0.59A	3ijxH-3h6tA: 42.6	3ijxH-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IJX_H_HCZH800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 5	LYS A 104 PRO A 105 SER A 108 LEU A 239	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) CYZ A 265 (-4.7A)	0.83A	3ijxH-3h6tA: 42.6	3ijxH-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK6_B_HCZB262_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	6 / 10	ILE A 92 PRO A 105 SER A 108 SER A 217 LYS A 218 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) GOL A 270 ( 3.0A) None None	0.34A	3ik6B-3h6tA: 43.4 3ik6E-3h6tA: 43.5	3ik6B-3h6tA: 100.00 3ik6E-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK6_B_HCZB800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	6 / 10	ILE A 92 PRO A 105 SER A 108 SER A 217 LYS A 218 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) GOL A 270 ( 3.0A) None None	0.61A	3ik6B-3h6tA: 43.4 3ik6E-3h6tA: 43.5	3ik6B-3h6tA: 100.00 3ik6E-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILT_B_TRUB800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	8 / 12	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.57A	3iltB-3h6tA: 37.5 3iltE-3h6tA: 37.0	3iltB-3h6tA: 100.00 3iltE-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILT_E_TRUE800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	8 / 10	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.57A	3iltB-3h6tA: 37.5 3iltE-3h6tA: 37.0	3iltB-3h6tA: 100.00 3iltE-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILT_H_TRUH800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	3 / 3	ILE A 92 SER A 108 SER A 217	None CYZ A 265 (-2.8A) GOL A 270 ( 3.0A)	0.42A	3iltH-3h6tA: 36.8	3iltH-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILU_B_HFZB800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 10	LYS A 104 PRO A 105 SER A 108 LEU A 239 SER A 242	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A)	0.65A	3iluB-3h6tA: 43.8 3iluE-3h6tA: 43.3	3iluB-3h6tA: 100.00 3iluE-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILU_E_HFZE800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	6 / 11	ILE A 92 PRO A 105 SER A 108 SER A 217 LYS A 218 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) GOL A 270 ( 3.0A) None None	0.57A	3iluB-3h6tA: 43.8 3iluE-3h6tA: 43.3	3iluB-3h6tA: 100.00 3iluE-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILU_H_HFZH800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 5	LYS A 104 PRO A 105 LEU A 239 SER A 242	None CYZ A 265 (-3.9A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A)	0.35A	3iluH-3h6tA: 43.1	3iluH-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ILU_H_HFZH800_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 5	LYS A 104 PRO A 105 SER A 108 LEU A 239	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) CYZ A 265 (-4.7A)	0.79A	3iluH-3h6tA: 43.1	3iluH-3h6tA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP5_B_KANB2002_1 (TRANSCRIPTIONAL REGULATOR TCAR)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	3 / 3	ALA A 134 ARG A 180 LYS A 183	None	1.12A	3kp5B-3h6tA: undetectable	3kp5B-3h6tA: 18.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSF_B_PZIB800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	6 / 10	TYR A 35 PRO A 105 MET A 107 SER A 108 SER A 242 LEU A 247	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A)	0.32A	3lsfB-3h6tA: 43.6 3lsfE-3h6tA: 43.0	3lsfB-3h6tA: 100.00 3lsfE-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSF_E_PZIE800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	6 / 10	PRO A 105 MET A 107 SER A 108 SER A 242 LEU A 247 LYS A 251	CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.30A	3lsfB-3h6tA: 43.6 3lsfE-3h6tA: 43.0	3lsfB-3h6tA: 100.00 3lsfE-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSF_H_PZIH800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 8	TYR A 35 MET A 107 SER A 108 ASP A 248 LYS A 251	None None CYZ A 265 (-2.8A) None CYZ A 265 ( 4.4A)	0.86A	3lsfH-3h6tA: 42.7	3lsfH-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSF_H_PZIH800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	7 / 8	TYR A 35 PRO A 105 MET A 107 SER A 108 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.31A	3lsfH-3h6tA: 42.7	3lsfH-3h6tA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_A_PZIA800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 7	TYR A 35 MET A 107 LEU A 247 ASP A 248 LYS A 251	None None CYZ A 265 (-4.3A) None CYZ A 265 ( 4.4A)	0.96A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_A_PZIA801_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 8	ILE A 92 PRO A 105 SER A 108 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) None	0.38A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_A_PZIA801_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 8	ILE A 92 PRO A 105 SER A 217 GLY A 219	None CYZ A 265 (-3.9A) GOL A 270 ( 3.0A) None	0.74A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_D_PZID800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 7	TYR A 35 MET A 107 ASP A 248 LYS A 251	None None None CYZ A 265 ( 4.4A)	1.08A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_D_PZID800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 7	TYR A 35 MET A 107 LEU A 247 LYS A 251	None None CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.49A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_D_PZID801_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 8	ILE A 92 PRO A 105 SER A 108 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) None	0.27A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_D_PZID801_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 8	ILE A 92 PRO A 105 SER A 217 GLY A 219	None CYZ A 265 (-3.9A) GOL A 270 ( 3.0A) None	0.68A	3lslA-3h6tA: 42.6 3lslD-3h6tA: 42.7	3lslA-3h6tA: 99.61 3lslD-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_G_PZIG800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 6	TYR A 35 MET A 107 ASP A 248 LYS A 251	None None None CYZ A 265 ( 4.4A)	1.03A	3lslG-3h6tA: 42.1	3lslG-3h6tA: 99.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LSL_G_PZIG800_0 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 6	TYR A 35 MET A 107 LEU A 247 LYS A 251	None None CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.45A	3lslG-3h6tA: 42.1	3lslG-3h6tA: 99.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P73_A_ACTA275_0 (MHC RFP-Y CLASS I ALPHA CHAIN)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	3 / 3	ILE A 200 VAL A 178 ARG A 182	None	0.59A	3p73A-3h6tA: undetectable	3p73A-3h6tA: 21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S45_B_478B201_2 (PROTEASE)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 11	LEU A 39 ALA A 237 GLY A 231 ILE A 87 ILE A 43	None	0.87A	3s45B-3h6tA: undetectable	3s45B-3h6tA: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S54_B_017B201_1 (PROTEASE)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 12	LEU A 39 ALA A 237 GLY A 231 ILE A 87 ILE A 43	None	0.87A	3s54A-3h6tA: undetectable	3s54A-3h6tA: 16.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKD_A_CYZA266_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	8 / 9	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.26A	3tkdA-3h6tA: 44.2	3tkdA-3h6tA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKD_A_CYZA266_2 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 5	ILE A 92 PRO A 105 SER A 217 LYS A 218 GLY A 219	None CYZ A 265 (-3.9A) GOL A 270 ( 3.0A) None None	0.18A	3tkdB-3h6tA: 42.7	3tkdB-3h6tA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKD_B_CYZB267_1 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 5	ILE A 92 PRO A 105 SER A 217 LYS A 218 GLY A 219	None CYZ A 265 (-3.9A) GOL A 270 ( 3.0A) None None	0.17A	3tkdA-3h6tA: 44.2	3tkdA-3h6tA: 99.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3TKD_B_CYZB267_2 (GLUTAMATE RECEPTOR 2)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	8 / 9	LYS A 104 PRO A 105 MET A 107 SER A 108 LEU A 239 SER A 242 LEU A 247 LYS A 251	None CYZ A 265 (-3.9A) None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-2.9A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.36A	3tkdB-3h6tA: 42.7	3tkdB-3h6tA: 99.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IB4_A_ERMA2001_2 (CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 7	THR A 224 LEU A 236 GLN A 244 LEU A 241	None	1.01A	4ib4A-3h6tA: undetectable	4ib4A-3h6tA: 21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ODO_A_FK5A205_2 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 4	THR A 93 ARG A 149 GLU A 145 VAL A 95	None	1.40A	4odoC-3h6tA: undetectable	4odoC-3h6tA: 18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E5J_A_017A201_2 (PROTEASE)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 12	LEU A 39 ALA A 237 GLY A 231 ILE A 87 ILE A 43	None	0.88A	5e5jB-3h6tA: undetectable	5e5jB-3h6tA: 16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JHD_E_EDTE301_0 (BETA-2-MICROGLOBULIN TCRBETA CHAIN)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 8	SER A 142 THR A 91 THR A 93 ILE A 111	GLU A 264 (-3.2A) GLU A 264 (-4.2A) None None	1.04A	5jhdE-3h6tA: undetectable 5jhdG-3h6tA: undetectable	5jhdE-3h6tA: 21.55 5jhdG-3h6tA: 16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJC_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 7	LEU A 127 THR A 143 TRP A 159 MET A 162	None GLU A 264 (-3.6A) None None	1.42A	5ljcA-3h6tA: undetectable	5ljcA-3h6tA: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_B_CVIB301_1 (REGULATORY PROTEIN TETR)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 8	GLY A 62 TYR A 190 ASP A 139 ASP A 65	None	1.05A	5vlmB-3h6tA: undetectable	5vlmB-3h6tA: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_E_CVIE301_1 (REGULATORY PROTEIN TETR)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	4 / 7	GLY A 62 TYR A 190 ASP A 139 ASP A 65	None	1.10A	5vlmE-3h6tA: undetectable	5vlmE-3h6tA: 20.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WEO_A_CYZA1302_1 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT CHIMERA)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 10	ILE A 92 PRO A 105 SER A 108 SER A 217 GLY A 219	None CYZ A 265 (-3.9A) CYZ A 265 (-2.8A) GOL A 270 ( 3.0A) None	0.54A	5weoA-3h6tA: 8.2 5weoD-3h6tA: 7.2	5weoA-3h6tA: 34.03 5weoD-3h6tA: 34.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM0_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 10	MET A 107 SER A 108 LEU A 239 LEU A 247 LYS A 251	None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.76A	6dm0B-3h6tA: 35.3 6dm0C-3h6tA: 21.2	6dm0B-3h6tA: 15.44 6dm0C-3h6tA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM0_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 9	MET A 107 SER A 108 LEU A 239 LEU A 247 LYS A 251	None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.77A	6dm0A-3h6tA: 21.2 6dm0D-3h6tA: 1.4	6dm0A-3h6tA: 15.44 6dm0D-3h6tA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 10	MET A 107 SER A 108 LEU A 239 LEU A 247 LYS A 251	None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.76A	6dm2B-3h6tA: 35.6 6dm2C-3h6tA: 29.1	6dm2B-3h6tA: 15.44 6dm2C-3h6tA: 15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3h6t	GLUTAMATE RECEPTOR 2 (Rattus norvegicus)	5 / 10	MET A 107 SER A 108 LEU A 239 LEU A 247 LYS A 251	None CYZ A 265 (-2.8A) CYZ A 265 (-4.7A) CYZ A 265 (-4.3A) CYZ A 265 ( 4.4A)	0.76A	6dm2A-3h6tA: 29.1 6dm2D-3h6tA: 35.9	6dm2A-3h6tA: 15.44 6dm2D-3h6tA: 15.44

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1LBC_A_CYZA330_1","GLUTAMINE RECEPTOR 2;GLUTAMINE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",8,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.35A","1lbcA-3h6tA:44.1;1lbcC-3h6tA:43.4","1lbcA-3h6tA:100.00;1lbcC-3h6tA:100.00"],["1LBC_B_CYZB329_1","GLUTAMINE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",9,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;ASP A 248;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);None;CYZ A 265 ( 4.4A)","0.46A","1lbcB-3h6tA:43.6","1lbcB-3h6tA:100.00"],["1LBC_C_CYZC331_1","GLUTAMINE RECEPTOR 2;GLUTAMINE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",8,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.37A","1lbcA-3h6tA:44.1;1lbcC-3h6tA:43.4","1lbcA-3h6tA:100.00;1lbcC-3h6tA:100.00"],["1P91_A_SAMA1401_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE A","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"LEU A 138;GLY A  62;ILE A  11;TYR A  16;PRO A  15","GLU A 264 (-4.6A);None;None;None;None","1.17A","1p91A-3h6tA:undetectable","1p91A-3h6tA:21.69"],["1VPO_H_TESH1010_1","ANTI-TESTOSTERONE (HEAVY CHAIN);ANTI-TESTOSTERONE (LIGHT CHAIN)","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"ALA A 189;GLY A 136;LEU A 191;PHE A 147;VAL A 154","None","1.34A","1vpoH-3h6tA:undetectable;1vpoL-3h6tA:undetectable","1vpoH-3h6tA:20.36;1vpoL-3h6tA:23.02"],["3EBZ_B_017B201_1","PROTEASE;PROTEASE","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"LEU A  39;ALA A 237;GLY A 231;ILE A  87;ILE A  43","None","0.83A","3ebzA-3h6tA:undetectable","3ebzA-3h6tA:17.57"],["3IJX_B_HCZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"ILE A  92;PRO A 105;SER A 108;SER A 217;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);GOL A 270 ( 3.0A);None","0.64A","3ijxB-3h6tA:42.8;3ijxD-3h6tA:42.7","3ijxB-3h6tA:100.00;3ijxD-3h6tA:100.00"],["3IJX_H_HCZH800_1","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"LYS A 104;PRO A 105;LEU A 239;SER A 242","None;CYZ A 265 (-3.9A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A)","0.59A","3ijxH-3h6tA:42.6","3ijxH-3h6tA:100.00"],["3IJX_H_HCZH800_1","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"LYS A 104;PRO A 105;SER A 108;LEU A 239","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);CYZ A 265 (-4.7A)","0.83A","3ijxH-3h6tA:42.6","3ijxH-3h6tA:100.00"],["3IK6_B_HCZB262_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",6,"ILE A  92;PRO A 105;SER A 108;SER A 217;LYS A 218;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);GOL A 270 ( 3.0A);None;None","0.34A","3ik6B-3h6tA:43.4;3ik6E-3h6tA:43.5","3ik6B-3h6tA:100.00;3ik6E-3h6tA:100.00"],["3IK6_B_HCZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",6,"ILE A  92;PRO A 105;SER A 108;SER A 217;LYS A 218;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);GOL A 270 ( 3.0A);None;None","0.61A","3ik6B-3h6tA:43.4;3ik6E-3h6tA:43.5","3ik6B-3h6tA:100.00;3ik6E-3h6tA:100.00"],["3ILT_B_TRUB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",8,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.57A","3iltB-3h6tA:37.5;3iltE-3h6tA:37.0","3iltB-3h6tA:100.00;3iltE-3h6tA:100.00"],["3ILT_E_TRUE800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",8,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.57A","3iltB-3h6tA:37.5;3iltE-3h6tA:37.0","3iltB-3h6tA:100.00;3iltE-3h6tA:100.00"],["3ILT_H_TRUH800_1","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",3,"ILE A  92;SER A 108;SER A 217","None;CYZ A 265 (-2.8A);GOL A 270 ( 3.0A)","0.42A","3iltH-3h6tA:36.8","3iltH-3h6tA:100.00"],["3ILU_B_HFZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"LYS A 104;PRO A 105;SER A 108;LEU A 239;SER A 242","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A)","0.65A","3iluB-3h6tA:43.8;3iluE-3h6tA:43.3","3iluB-3h6tA:100.00;3iluE-3h6tA:100.00"],["3ILU_E_HFZE800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",6,"ILE A  92;PRO A 105;SER A 108;SER A 217;LYS A 218;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);GOL A 270 ( 3.0A);None;None","0.57A","3iluB-3h6tA:43.8;3iluE-3h6tA:43.3","3iluB-3h6tA:100.00;3iluE-3h6tA:100.00"],["3ILU_H_HFZH800_1","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"LYS A 104;PRO A 105;LEU A 239;SER A 242","None;CYZ A 265 (-3.9A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A)","0.35A","3iluH-3h6tA:43.1","3iluH-3h6tA:100.00"],["3ILU_H_HFZH800_1","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"LYS A 104;PRO A 105;SER A 108;LEU A 239","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);CYZ A 265 (-4.7A)","0.79A","3iluH-3h6tA:43.1","3iluH-3h6tA:100.00"],["3KP5_B_KANB2002_1","TRANSCRIPTIONAL REGULATOR TCAR","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",3,"ALA A 134;ARG A 180;LYS A 183","None","1.12A","3kp5B-3h6tA:undetectable","3kp5B-3h6tA:18.40"],["3LSF_B_PZIB800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",6,"TYR A  35;PRO A 105;MET A 107;SER A 108;SER A 242;LEU A 247","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A)","0.32A","3lsfB-3h6tA:43.6;3lsfE-3h6tA:43.0","3lsfB-3h6tA:100.00;3lsfE-3h6tA:100.00"],["3LSF_E_PZIE800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",6,"PRO A 105;MET A 107;SER A 108;SER A 242;LEU A 247;LYS A 251","CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.30A","3lsfB-3h6tA:43.6;3lsfE-3h6tA:43.0","3lsfB-3h6tA:100.00;3lsfE-3h6tA:100.00"],["3LSF_H_PZIH800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"TYR A  35;MET A 107;SER A 108;ASP A 248;LYS A 251","None;None;CYZ A 265 (-2.8A);None;CYZ A 265 ( 4.4A)","0.86A","3lsfH-3h6tA:42.7","3lsfH-3h6tA:100.00"],["3LSF_H_PZIH800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",7,"TYR A  35;PRO A 105;MET A 107;SER A 108;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.31A","3lsfH-3h6tA:42.7","3lsfH-3h6tA:100.00"],["3LSL_A_PZIA800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"TYR A  35;MET A 107;LEU A 247;ASP A 248;LYS A 251","None;None;CYZ A 265 (-4.3A);None;CYZ A 265 ( 4.4A)","0.96A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_A_PZIA801_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"ILE A  92;PRO A 105;SER A 108;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);None","0.38A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_A_PZIA801_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"ILE A  92;PRO A 105;SER A 217;GLY A 219","None;CYZ A 265 (-3.9A);GOL A 270 ( 3.0A);None","0.74A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_D_PZID800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"TYR A  35;MET A 107;ASP A 248;LYS A 251","None;None;None;CYZ A 265 ( 4.4A)","1.08A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_D_PZID800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"TYR A  35;MET A 107;LEU A 247;LYS A 251","None;None;CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.49A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_D_PZID801_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"ILE A  92;PRO A 105;SER A 108;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);None","0.27A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_D_PZID801_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"ILE A  92;PRO A 105;SER A 217;GLY A 219","None;CYZ A 265 (-3.9A);GOL A 270 ( 3.0A);None","0.68A","3lslA-3h6tA:42.6;3lslD-3h6tA:42.7","3lslA-3h6tA:99.61;3lslD-3h6tA:99.61"],["3LSL_G_PZIG800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"TYR A  35;MET A 107;ASP A 248;LYS A 251","None;None;None;CYZ A 265 ( 4.4A)","1.03A","3lslG-3h6tA:42.1","3lslG-3h6tA:99.61"],["3LSL_G_PZIG800_0","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"TYR A  35;MET A 107;LEU A 247;LYS A 251","None;None;CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.45A","3lslG-3h6tA:42.1","3lslG-3h6tA:99.61"],["3P73_A_ACTA275_0","MHC RFP-Y CLASS I ALPHA CHAIN","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",3,"ILE A 200;VAL A 178;ARG A 182","None","0.59A","3p73A-3h6tA:undetectable","3p73A-3h6tA:21.77"],["3S45_B_478B201_2","PROTEASE","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"LEU A  39;ALA A 237;GLY A 231;ILE A  87;ILE A  43","None","0.87A","3s45B-3h6tA:undetectable","3s45B-3h6tA:17.57"],["3S54_B_017B201_1","PROTEASE;PROTEASE","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"LEU A  39;ALA A 237;GLY A 231;ILE A  87;ILE A  43","None","0.87A","3s54A-3h6tA:undetectable","3s54A-3h6tA:16.34"],["3TKD_A_CYZA266_1","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",8,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.26A","3tkdA-3h6tA:44.2","3tkdA-3h6tA:99.62"],["3TKD_A_CYZA266_2","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"ILE A  92;PRO A 105;SER A 217;LYS A 218;GLY A 219","None;CYZ A 265 (-3.9A);GOL A 270 ( 3.0A);None;None","0.18A","3tkdB-3h6tA:42.7","3tkdB-3h6tA:99.62"],["3TKD_B_CYZB267_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"ILE A  92;PRO A 105;SER A 217;LYS A 218;GLY A 219","None;CYZ A 265 (-3.9A);GOL A 270 ( 3.0A);None;None","0.17A","3tkdA-3h6tA:44.2","3tkdA-3h6tA:99.62"],["3TKD_B_CYZB267_2","GLUTAMATE RECEPTOR 2","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",8,"LYS A 104;PRO A 105;MET A 107;SER A 108;LEU A 239;SER A 242;LEU A 247;LYS A 251","None;CYZ A 265 (-3.9A);None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-2.9A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.36A","3tkdB-3h6tA:42.7","3tkdB-3h6tA:99.62"],["4IB4_A_ERMA2001_2","CHIMERA PROTEIN OF HUMAN 5-HYDROXYTRYPTAMINE RECEPTOR 2B AND E. COLI SOLUBLE CYTOCHROME B562","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"THR A 224;LEU A 236;GLN A 244;LEU A 241","None","1.01A","4ib4A-3h6tA:undetectable","4ib4A-3h6tA:21.03"],["4ODO_A_FK5A205_2","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD;PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SLYD","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"THR A  93;ARG A 149;GLU A 145;VAL A  95","None","1.40A","4odoC-3h6tA:undetectable","4odoC-3h6tA:18.53"],["5E5J_A_017A201_2","PROTEASE;PROTEASE","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"LEU A  39;ALA A 237;GLY A 231;ILE A  87;ILE A  43","None","0.88A","5e5jB-3h6tA:undetectable","5e5jB-3h6tA:16.34"],["5JHD_E_EDTE301_0","BETA-2-MICROGLOBULIN;TCRBETA CHAIN","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"SER A 142;THR A  91;THR A  93;ILE A 111","GLU A 264 (-3.2A);GLU A 264 (-4.2A);None;None","1.04A","5jhdE-3h6tA:undetectable;5jhdG-3h6tA:undetectable","5jhdE-3h6tA:21.55;5jhdG-3h6tA:16.35"],["5LJC_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"LEU A 127;THR A 143;TRP A 159;MET A 162","None;GLU A 264 (-3.6A);None;None","1.42A","5ljcA-3h6tA:undetectable","5ljcA-3h6tA:19.51"],["5VLM_B_CVIB301_1","REGULATORY PROTEIN TETR","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"GLY A  62;TYR A 190;ASP A 139;ASP A  65","None","1.05A","5vlmB-3h6tA:undetectable","5vlmB-3h6tA:20.72"],["5VLM_E_CVIE301_1","REGULATORY PROTEIN TETR","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",4,"GLY A  62;TYR A 190;ASP A 139;ASP A  65","None","1.10A","5vlmE-3h6tA:undetectable","5vlmE-3h6tA:20.72"],["5WEO_A_CYZA1302_1","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT CHIMERA;GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT CHIMERA","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"ILE A  92;PRO A 105;SER A 108;SER A 217;GLY A 219","None;CYZ A 265 (-3.9A);CYZ A 265 (-2.8A);GOL A 270 ( 3.0A);None","0.54A","5weoA-3h6tA:8.2;5weoD-3h6tA:7.2","5weoA-3h6tA:34.03;5weoD-3h6tA:34.03"],["6DM0_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"MET A 107;SER A 108;LEU A 239;LEU A 247;LYS A 251","None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.76A","6dm0B-3h6tA:35.3;6dm0C-3h6tA:21.2","6dm0B-3h6tA:15.44;6dm0C-3h6tA:15.44"],["6DM0_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"MET A 107;SER A 108;LEU A 239;LEU A 247;LYS A 251","None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.77A","6dm0A-3h6tA:21.2;6dm0D-3h6tA:1.4","6dm0A-3h6tA:15.44;6dm0D-3h6tA:15.44"],["6DM2_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"MET A 107;SER A 108;LEU A 239;LEU A 247;LYS A 251","None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.76A","6dm2B-3h6tA:35.6;6dm2C-3h6tA:29.1","6dm2B-3h6tA:15.44;6dm2C-3h6tA:15.44"],["6DM2_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3h6t","GLUTAMATE RECEPTOR 2","Rattus norvegicus",5,"MET A 107;SER A 108;LEU A 239;LEU A 247;LYS A 251","None;CYZ A 265 (-2.8A);CYZ A 265 (-4.7A);CYZ A 265 (-4.3A);CYZ A 265 ( 4.4A)","0.76A","6dm2A-3h6tA:29.1;6dm2D-3h6tA:35.9","6dm2A-3h6tA:15.44;6dm2D-3h6tA:15.44"]]